Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health
CCR - For Our Staff| Home |

Our Science – Amarnath Website

Shoba M. Amarnath, Ph.D.

Selected Publications

1)  Amarnath S.
c-Rel in GVHD biology: A missing link.
Eur.J.Immunol. 43(9): 2255-2258, 2013.
2)  Felizardo TC, Foley J, Steed K, Dropulic B, Amarnath S, Medin JA, Fowler DH.
Harnessing autophagy for cell fate control gene therapy.
Autophagy. 9, 2013.
3)  Amarnath S, Barrett AJ.
Mesenchymal stromal cells: heroes or non-combatants?.
Cytotherapy. 15: 253-4, 2013.
4)  Mangus CW, Massey PR, Fowler DH, Amarnath S.
Rapamycin resistant murine th9 cells have a stable in vivo phenotype and inhibit graft-versus-host reactivity.
PLoS ONE. 8: e72305, 2013.
5)  Klionsky et al DJ.
Guidelines for the use and interpretation of assays for monitoring autophagy.
Autophagy. 8: 445-544, 2012.
6)  Amarnath S, Fowler DH.
Harnessing autophagy for adoptive T-cell therapy.
Immunotherapy. 4: 1-4, 2012.
7)  Vázquez N, Rekka S, Gliozzi M, Feng CG, Amarnath S, Orenstein JM, Wahl SM.
Modulation of Innate Host Factors by Mycobacterium avium Complex in Human Macrophages Includes Interleukin 17.
J. Infect. Dis. 206: 1206-17, 2012.
8)  *Laurence A, *Amarnath S, Mariotti J, Kim YC, Foley J, Eckhaus M, O'Shea JJ, Fowler DH.
STAT3 Transcription Factor Promotes Instability of nTreg Cells and Limits Generation of iTreg Cells during Acute Murine Graft-versus-Host Disease. (*equally contributing authors).
Immunity. 37: 209-22, 2012.
9)  *Amarnath S, *Chen H, Foley JE, Costanzo CM, Sennesh JD, Solomon MA, Fowler DH.
Host-based th2 cell therapy for prolongation of cardiac allograft viability (*equally contributing authors).
PLoS ONE. 6: e18885, 2011.
10)  Miller TW, Wang EA, Gould S, Stein EV, Kaur S, Lim L, Amarnath S, Fowler DH, Roberts DD.
Hydrogen sulfide is an endogenous potentiator of T cell activation.
J Biol Chem. 287: 4211-21, 2011.
Click Here to View Expanded Bibliography.

This page was last updated on 6/17/2014.